884494-53-5 Usage
Uses
Used in Pharmaceutical Industry:
3-Bromo-2-chloro-4-iodopyridine is used as a building block for the synthesis of complex organic molecules, particularly in the development of new drugs. Its unique chemical structure allows for the creation of biologically active compounds, making it a valuable tool for researchers in organic chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Bromo-2-chloro-4-iodopyridine serves as a key intermediate in the synthesis of pesticides and herbicides. Its potential applications in these areas contribute to the development of more effective and targeted agricultural chemicals.
Used in Organic Chemistry Research:
3-Bromo-2-chloro-4-iodopyridine is utilized as an important intermediate for the synthesis of biologically active compounds in organic chemistry research. Its unique structure provides opportunities for the exploration of new chemical reactions and the discovery of novel compounds with potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 884494-53-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,4,4,9 and 4 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 884494-53:
(8*8)+(7*8)+(6*4)+(5*4)+(4*9)+(3*4)+(2*5)+(1*3)=225
225 % 10 = 5
So 884494-53-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H2BrClIN/c6-4-3(8)1-2-9-5(4)7/h1-2H
884494-53-5Relevant academic research and scientific papers
Triazolopyridine cannabinoid receptor 1 antagonists
-
Page/Page column 36, (2008/06/13)
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents, and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formula: including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein R1, R2, R3, R4 and R5 are described herein.
